JASMINE WHITCOMB: Open Payments
NPI 1629779160 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,164 in 33 payments from 4 companies in 2025. Trend: 2023 $164 · 2024 $2,503 · 2025 $12,164
Consulting: $11,720Food & beverage: $350Education: $94
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 24 | $11,926 |
| Astellas Pharma US Inc | 4 | $171 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $43 |
| Evofem Biosciences, Inc. | 1 | $24 |
Products named: SLYND, TWIRLA, Veozah, Phexxi.
Industry payments across MD — which companies pay providers there.
